The effects of habekacin on corneal ulceration, caused by Pseudonnonas aeruginosa IFO 3455, were studied in mice, in comparison with gentamicin and tobramycin.
The corneal ulcer caused by Pseudomonas aeruginosa is a problem in terms of effective antibacterial therapeutics. Even with the administration of appropriate antibiotics, prompt destruction of the corneal stroma is observed, resulting in corneal perforation. Gentamicin and tobramycin have been reported to exhibit marked effects on experimental Pseudomonas keratitis',1,5~, and are now clinically used The Organism A protease-and elastase-producing strain IFO 3455 of Pseudomonas aeruginosa was kindly supplied by Dr. J. Y. HoMMA, Kitasato Institute, Tokyo, Japan. The cells, grown overnight on heart infusion agar,were suspended in 50% skim milk, frozen and kept at -70°C.
In each experiment, the frozen bacteria were brought to room temperature, and grown overnight on heart infusion agar. The successive culture, suspended in sterile saline (ca. 107 cells/ml), was used for the challenge to mice.
Sensitivity of Pseudomonas aeruginosa IFO 3455 to Antibiotics
The minimal inhibitory concentrations (MIC) were determined by liquid dilution method, using heart infusion broth. MICs were: habekacin 2 pi.g/ml, gentamicin 2 pp.g/ml, and tobramycin I pcg/ml. Animals Seven week-old male ddY mice were employed, weighing about 25 g. Every eye was confirmed to possess no pathological changes by hand-held slit-lamp examination, prior to bacterial inoculation. In every experiment, each group consisted of six mice.
Inoculation of the Organism to Mice Cornea Mice were anesthetized by intraperitoneal injection of 0.2 ml of 1 : 10 diluted Nembutal (Abbott Lab.), containing 1 mg pentobarbital sodium. The cornea was incised in the central area at three spots with a subcutaneous needle (1/4 gauge) under a magnifying glass. The traumatized cornea was deposited once with a drop of about 0.01 ml of the above-described bacterial suspension, which contained approximately 101 cells. Sterile saline was applied in the same manner instead of the Pseudomonas inoculation, as control. The antibiotics were administered topically and/or intramuscularly, as described below; and control animals were treated with sterile saline instead of the drugs in the same procedure.
All the corneas were evaluated blindly for severity of damage, and graded as presented in Table 1 .
Results

Mouse Protection by the Topical Application of Aminoglycosides against
Corneal Damage Produced by Pseudomonas aeruginosa IFO 3455 Solutions of 9, 3 and 1 pig habekacin, 3 pig gentamicin, and 3 pig tobramycin, in 0.01 ml of saline, were topically applied three hours after the bacterial challenge. Six mice were used in each group.
The pathological changes were observed 24 hours after the infection. As shown in Table 2 , complete protection was found in 6 (100 %), 5 (83 %) and 3 (50 %) mice in the groups administered with 9, 3 and 1 pig habekacin per mouse, respectively. Therefore, the ED,, value of habekacin seemed to be ca. 1 p'g per mouse, when dropped onto the cornea. In simultaneous experiments, 3 pig of gentamicin or tobramycin showed complete prophylactic effects in all the mice. Thus, habekacin exhibited a significant protection against Pseudomonas keratitis to a similar degree as gentamicin and tobramycin. 
Protective Effects of Antibiotics on Pseudomonas Keratitis by Intramuscular Administration
Habekacin (1.6, 0.4, 0.1 and 0.025 mg), gentamicin (0.2 mg), and tobramycin (0.2 mg) in 0.05 ml were injected into the leg muscle (quadriceps), an hour after the Pseudomonas challenge to the corneas.
Each group consisted of six mice. The corneal changes were observed 24 hours after the infection.
Complete protection was found in 6 (100'//o'), 4 (67 %), 1 (17 %), and 0 in the groups given 1.6, 0.4, 0.1 and 0.025 mg habekacin per mouse, respectively. All the animals injected with the antibiotic exhibited less grades of corneal damage than the control group. The ED,, value of habekacin (i.m.), therefore, was approximately 0.2 mg per mouse.
In parallel experiments, the complete protective effects were observed in 4 mice (67 %) with 0.2 mg gentamicin, and in 5 mice (83 %) with 0.2 mg tobramycin (Table 3) .
Therapeutic Effects of Aminoglycosides on Pseudomonas Ulceration by the Topical Application
The corneal damage of grade I or II was constantly observed 15 hours after bacterial challenge.
Starting the treatment at 15 hours, the therapeutic effects of habekacin were studied. A drop (ca.
0.01 ml) of 40 or 3 mg/ml of the antibiotic solution was topically applied three times with an hour intervals every morning and evening. In simultaneous experiments, tobramycin was given in the same manner. The gross finding of pathological changes was recorded everyday ( Table 4 ). The average of grading scales of corneal damage is illustrated in Fig. 2 . Habekacin exhibited a significant therapeutic effect on a similar level as tobramycin. However, the complete cure of corneal lesion was not observed by the antibiotic treatment in a week.
Therapeutic Effects of Antibiotics on Pseudomonas Keratitis by Both Topical and Intramuscular Administrations
Since no complete cure could be obtained by the topical application of the antibiotics within a week, the drugs were given by both intramuscular and topical routes, starting 15 hours after the bacterial infection. The antibiotic solutions of 40 and 3 mg/ml were administered intramuscularly once a day with 0.05 ml, and topically with 0.01 ml twice a day. In parallel groups, tobramycin or gentamicin was given in the same procedure. The pathological changes of corneas were observed every day ( Table 5 ). The average of grading scales of the corneal lesion is presented in Fig. 3 . Habekacin showed significant therapeutic and protective effects to a similar degree as gentamicin and tobramycin.
A complete cure was found in a mouse with a higher dose of habekacin or tobramycin, and in two mice with that of gentamicin. Habekacin is effective against some gentamicin-and/or tobramycin-resistant bacteria',). Early antibiotic treatment is required to minimize the corneal damage. However, no corneal perforation and/or panopluhalmitis were observed in those cases in which the administration of habekacin was started after the formation of corneal ulcers. Histologic studies showed that pathological changes were limited to the cornea in habekacin-treated cases. In contrast, the changes were extended to intraocular infections in the control eyes. Corneas treated with the antibiotic were culture-negative for Pseudomonas aeruginosa on day 7, and bacteria were not detected in Gram stains of the tissue sections (Data are not shown). 
